We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roxane Fails to Block Hetero’s Generic PhosLo
Subsidiaries of generics maker Hetero Drugs can move forward with generic versions of the kidney drug PhosLo despite an ongoing lawsuit brought by patent owner Roxane Laboratories.